Mechanisms of coronavirus cell entry mediated by the viral spike protein

Sandrine BelouzardGary R Whittaker


Coronaviruses are enveloped positive-stranded RNA viruses that replicate in the cytoplasm. To deliver their nucleocapsid into the host cell, they rely on the fusion of their envelope with the host cell membrane. The spike glycoprotein (S) mediates virus entry and is a primary determinant of cell tropism and pathogenesis. It is classified as a class I fusion protein, and is responsible for binding to the receptor on the host cell as well as mediating the fusion of host and viral membranes-A process driven by major conformational changes of the S protein. This review discusses coronavirus entry mechanisms focusing on the different triggers used by coronaviruses to initiate the conformational change of the S protein: receptor binding, low pH exposure and proteolytic activation. We also highlight commonalities between coronavirus S proteins and other class I viral fusion proteins, as well as distinctive features that confer distinct tropism, pathogenicity and host interspecies transmission characteristics to coronaviruses.


Jan 1, 1987·Advances in Experimental Medicine and Biology·N C Pedersen
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·G S DvekslerK V Holmes
Jun 28, 2001·Bioscience Reports·I Martin, J M Ruysschaert
Oct 3, 2001·Journal of Neurovirology·J J PhillipsS R Weiss
Jan 5, 2002·Journal of Virology·Fumihiro Taguchi, Shutoku Matsuyama
Nov 5, 2002·Journal of Virology·Shutoku Matsuyama, Fumihiro Taguchi
Mar 29, 2003·Journal of Virology·Bert Jan HaijemaPeter J M Rottier
Oct 15, 2003·Journal of Virology·Christel Schwegmann-WesselsGeorg Herrler
Mar 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·Graham SimmonsPaul Bates
Jul 1, 2004·FEBS Letters·María J GómaraJosé L Nieva
Oct 22, 2004·Proceedings of the National Academy of Sciences of the United States of America·Scott A JeffersKathryn V Holmes
Nov 24, 2004·Biochemical and Biophysical Research Communications·Andrea BerniniNeri Niccolai
Dec 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Vinit M SupekarAndrea Carfí
Mar 26, 2005·The EMBO Journal·Wenhui LiMichael Farzan
Jun 4, 2005·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A T Da PoianF Stauffer
Aug 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Graham SimmonsPaul Bates
Aug 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·Shutoku MatsuyamaFumihiro Taguchi
Oct 8, 2005·Journal of Structural and Functional Genomics·Xun ZuoTauseef R Butt
Oct 29, 2005·Journal of Virology·Cornelis A M de HaanPeter J M Rottier

❮ Previous
Next ❯


Aug 8, 2013·The Journal of Infectious Diseases·Edward E WalshAnn R Falsey
Jun 14, 2014·Genome Announcements·Paulraj K LawrenceRoger E Bumgarner
Aug 13, 2014·Proceedings of the National Academy of Sciences of the United States of America·Yang YangFang Li
Jun 18, 2014·Nature Reviews. Rheumatology·Gary S Hoffman, Leonard H Calabrese
Apr 10, 2015·Viruses·Makoto Ujike, Fumihiro Taguchi
Feb 8, 2013·Journal of Peptide Science : an Official Publication of the European Peptide Society·Stefania GaldieroMassimiliano Galdiero
Apr 17, 2014·Reviews in Medical Virology·Yingying Cong, Xiaofeng Ren
May 9, 2015·Journal of Immunology Research·Faruku BandeAbdul Rahman Omar
Mar 1, 2016·Pathogens and Global Health·Ali S OmraniZiad A Memish
Dec 3, 2014·Virus Research·Jean Kaoru Millet, Gary R Whittaker
Dec 3, 2014·Virus Research·Juan RegueraJosé M Casasnovas
Oct 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Jean Kaoru Millet, Gary R Whittaker
Feb 16, 2016·Traffic·Yohei Yamauchi, Urs F Greber
Nov 7, 2014·PLoS Pathogens·Christine BurkardCornelis A M de Haan
Jun 5, 2016·Virus Research·Dang WangShaobo Xiao
Jun 19, 2016·Virus Research·Wentao LiBerend-Jan Bosch
Jul 19, 2016·Antiviral Research·Jean K MilletSandrine Belouzard
Jul 30, 2016·Antiviral Research·Qihui WangGeorge F Gao
Oct 21, 2016·ACS Infectious Diseases·Aleksandar AntanasijevicMichael Caffrey
Aug 26, 2016·Archives of Virology·Yingshun ZhouHui Liu
Sep 1, 2016·Annual Review of Virology·Fang Li
Feb 27, 2014·Veterinary Pathology·A Kipar, M L Meli
Dec 13, 2016·Expert Review of Anti-infective Therapy·Jaffar A Al-Tawfiq, Ziad A Memish
Feb 14, 2017·Journal of Medical Virology·Geoffrey J GorseXiaofeng Fan
Nov 29, 2016·Scientific Reports·Luis G M BassoAntonio J Costa-Filho
Sep 1, 2017·Journal of Medical Microbiology·Ali A RabaanHatem M Alhani

❮ Previous
Next ❯

Methods Mentioned


Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.